BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Rhea-AI Summary

BullFrog AI Holdings (NASDAQ: BFRG; BFRGW), a leader in AI-driven drug discovery, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference in New York City. The company's CEO, Vin Singh, will deliver a presentation that will be available on demand starting September 9, 2024, at 7:00am ET. Interested parties can access live and archived webcasts of the event through BullFrog AI's investor relations website at investors.bullfrogai.com. This participation provides an opportunity for the company to showcase its advancements in AI-driven drug discovery to a global investment audience.

Positive

• Participation in a major global investment conference, potentially increasing visibility to investors
• On-demand availability of CEO's presentation, allowing for wider audience reach

Negative

• None.

GAITHERSBURG, Md., Aug. 26, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a leader in AI-driven drug discovery, announced today that the Company will participate in the H.C. Wainwright 26th Annual Global Investment Conference being held in New York City.

Interested parties may access live and archived webcasts of these events on the company’s investor relations website at: investors.bullfrogai.com. The Company’s presentation by Vin Singh, Chief Executive Officer, will be available on demand commencing on September 9, 2024, at 7:00am ET.

About BullFrog AI:

BullFrog AI leverages Artificial Intelligence and machine learning to advance drug discovery and development. Through collaborations with leading research institutions, BullFrog AI uses causal AI in combination with its proprietary bfLEAP™ platform to analyze complex biological data, aiming to streamline therapeutics development and reduce failure rates in clinical trials. For more information, visit BullFrog AI at www.bullfrogai.com.

Contact:
Investors
Dave Gentry
RedChip Companies, Inc.
BFRG@redchip.com
1-407-644-4256

SOURCE: BullFrog AI Holdings, Inc.

FAQ

When is BullFrog AI (BFRG) presenting at the H.C. Wainwright Global Investment Conference?

BullFrog AI's presentation will be available on demand starting September 9, 2024, at 7:00am ET.

Who will be presenting for BullFrog AI (BFRG) at the investment conference?

Vin Singh, the Chief Executive Officer of BullFrog AI, will be delivering the company's presentation.

How can investors access BullFrog AI's (BFRG) presentation at the H.C. Wainwright conference?

Investors can access live and archived webcasts of the event through BullFrog AI's investor relations website at investors.bullfrogai.com.

What is BullFrog AI's (BFRG) primary focus in the biotech industry?

BullFrog AI is a leader in AI-driven drug discovery, using artificial intelligence to advance pharmaceutical development.